Advisor Group Holdings, Inc. Opgen Inc Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.32 - $0.79 $2,272 - $5,609	-7,100 Reduced 98.61%	100 $0
Q1 2022 May 04, 2022	BUY	$0.72 - $1.11 $1,152 - $1,776	1,600 Added 28.57%	7,200 $5,000
Q3 2021 Nov 05, 2021	BUY	$2.18 - $3.58 $2,180 - $3,580	1,000 Added 21.74%	5,600 $16,000
Q1 2021 May 13, 2021	BUY	$1.8 - $3.55 $1,800 - $3,550	1,000 Added 27.78%	4,600 $11,000
Q4 2020 Feb 10, 2021	BUY	$1.7 - $2.47 $5,950 - $8,645	3,500 Added 3500.0%	3,600 $7,000
Q3 2020 Nov 12, 2020	BUY	$1.98 - $3.37 $186 - $316	94 Added 1566.67%	100 $0
Q2 2020 Aug 14, 2020	SELL	$1.88 - $2.59 $5,640 - $7,770	-3,000 Reduced 99.8%	6 $0
Q1 2020 May 18, 2020	BUY	$1.14 - $4.04 $3,426 - $12,144	3,006 New	3,006 $8,000

Ticker OPGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,698,500
Market Cap $38.7M
Description
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.